
DMAA Market Capitalization Overview
Market Cap: $106.46M as of Jun 13, 2025
$106.46M
Past Month+$732.00K (0.69%)
As of Jun 13, 2025, DMAA has a market capitalization of $106.46M. Over the past 30 days, its market cap has increased by 0.59%, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of Drugs Made In America Acquisition Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
DMAA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of DMAA helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Drugs Made In America Acquisition Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
DMAA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of DMAA helps investors assess the company's size and compare it with competitors for better investment decisions.
DMAA Market Cap & Key Trends
See Drugs Made In America Acquisition Corp’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in DMAA
Order type
Buy in
Order amount
Est. shares
0 shares
DMAA Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $106.14M | +0.59% |
May 1, 2025 | $105.52M | +0.60% |
Apr 1, 2025 | $104.89M | +0.70% |
Mar 3, 2025 | $104.16M | -64.15% |
Feb 25, 2025 | $290.55M | — |
DMAA End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $106.46M | — |
FAQs About Drugs Made In America Acquisition Corp (DMAA) Market Cap
As of Jun 13, 2025, the market capitalization of DMAA is $106.46M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Drugs Made In America Acquisition Corp’s market capitalization has increased by 0.6900%, changing from $105.73M to $106.46M as of Jun 13, 2025.
In the last 3 months, Drugs Made In America Acquisition Corp’s market capitalization has increased by —, changing from – to – as of –.
In the year –, Drugs Made In America Acquisition Corp’s market capitalization increased from – in January to – in December, reflecting a — change.